AngioDynamics names Joseph DeVivo as its new CEO, replacing Jan Keltjens, and reveals the departure of one of its senior business development executives.
AngioDynamics Inc. (NSDQ:ANGO) named a replacement for former CEO Jan Keltjens, who left suddenly in June, tapping Joseph DeVivo for the corner office.
The Latham, N.Y.-based oncology device company also revealed the resignation of senior vice president of business development Lynda Wallace, according to SEC filings.
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading the respiratory devices company; plus, Hill-Rom names Alton Shader president for North America; Kinetic Concepts appoints former Stryker rep James Cunniff as senior VP of the Americas; Kips Bay promotes Scott Kellen to chief operating officer; and more.
Electromed (NSDQ:ELMD) founder, chairman & CEO Robert Hansen relinquished control of the company after 20 years steering the ship.
Contrary to a widely circulated statement, Covidien's decision to cut workers and shift production overseas was not motivated by the impending medical device tax, the company says.
Although Covidien (NYSE:COV) chairman, president & CEO Jose Almeida considers the impending 2.3% medical device tax "absurd," he's far from implementing dramatic gestures to cope with the new burden.
The company confirmed with MassDevice.com that reports of layoffs and overseas shifts ahead of the levy were inaccurate, despite being widely disseminated.
Edwards Lifesciences chairman & CEO Michael Mussallem will in May begin exercising his stock options under SEC rule 10b5-1; also SRS Medical promotes Lee Brody to the corner office; Advanced Cardiac Therapeutics shuffles the deck, builds its hand to support commercialization; CardioKinetix names Maria Sainz president & CEO; Zeltiq interim president & CEO Mark Foley to receive $50k per month; and more.
AtriCure shares are up nearly 15% today after the atrial fibrillation device maker reported lower-than-expected 1st-quarter losses and record revenues.
AtriCure (NSDQ:ATRC) shares gained nearly 15% this morning after it reported lower-than-expected losses and record revenues of $17.5 million for the 1st quarter.
The West Chester, Ohio-based atrial fibrillation device maker reported losses of $1.6 million, or 10¢ per share, on sales of $17.5 million for the 3 months ended March 31, representing an 11.8% top-line increase.
vRad promotes veteran George Morgan to CEO; SRS Medical promotes its former COO Lee Brody to the corner office; the Institute for Healthcare Improvement shuffles the deck; and more.
Static and Dynamic testing systems for materials, components, and devices. Systems range from 50 grams to 600kN of force capacity in tension, compression, torsion, and more.
Provides grips, fixtures, heating and cooling systems, and fluid baths.